Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M DeAngelis

Showing results (481-490 of 512) with videos related to

Pageof 52
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic GliomasAntonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS LymphomaChristian Grommes, Subhiksha Nandakumar, Lauren R Schaff, et al.
Mbio|March 25, 2024
Priorities, opportunities, and challenges for integrating microorganisms into Earth system models for climate change predictionJ T Lennon, R Z Abramoff, S D Allison, et al.
Neuro-Oncology|May 5, 2017
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendrogliomaAlissa A Thomas, Lauren E Abrey, Robert Terziev, et al.
Neuro-Oncology|December 23, 2015
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant gliomaMacarena I de la Fuente, Robert J Young, Jennifer Rubel, et al.
Human Molecular Genetics|August 23, 2022
Expression and subcellular localization of USH1C/harmonin in human retina provides insights into pathomechanisms and therapyKerstin Nagel-Wolfrum, Benjamin R Fadl, Mirjana M Becker, et al.
Science Signaling|December 17, 2009
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapyDeliang Guo, Robert M Prins, Julie Dang, et al.
Human Genomics|December 14, 2011
Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degenerationMargaux A Morrison, Alexandra C Silveira, Nancy Huynh, et al.
Cancer Discovery|November 8, 2011
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathwayDeliang Guo, Felicia Reinitz, Mary Youssef, et al.
Cell Genomics|June 30, 2023
A systems biology approach uncovers novel disease mechanisms in age-related macular degenerationLuz D Orozco, Leah A Owen, Jeffrey Hofmann, et al.
Pageof 52

Showing results (481-490 of 512) with videos related to

Sort By:
Pageof 52
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 24, 2018
Multicenter Phase IB Trial of Carboxyamidotriazole Orotate and Temozolomide for Recurrent and Newly Diagnosed Glioblastoma and Other Anaplastic GliomasAntonio Omuro, Kathryn Beal, Katharine McNeill, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 12, 2024
A Phase II Study Assessing Long-term Response to Ibrutinib Monotherapy in Recurrent or Refractory CNS LymphomaChristian Grommes, Subhiksha Nandakumar, Lauren R Schaff, et al.
Mbio|March 25, 2024
Priorities, opportunities, and challenges for integrating microorganisms into Earth system models for climate change predictionJ T Lennon, R Z Abramoff, S D Allison, et al.
Neuro-Oncology|May 5, 2017
Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendrogliomaAlissa A Thomas, Lauren E Abrey, Robert Terziev, et al.
Neuro-Oncology|December 23, 2015
Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant gliomaMacarena I de la Fuente, Robert J Young, Jennifer Rubel, et al.
Human Molecular Genetics|August 23, 2022
Expression and subcellular localization of USH1C/harmonin in human retina provides insights into pathomechanisms and therapyKerstin Nagel-Wolfrum, Benjamin R Fadl, Mirjana M Becker, et al.
Science Signaling|December 17, 2009
EGFR signaling through an Akt-SREBP-1-dependent, rapamycin-resistant pathway sensitizes glioblastomas to antilipogenic therapyDeliang Guo, Robert M Prins, Julie Dang, et al.
Human Genomics|December 14, 2011
Systems biology-based analysis implicates a novel role for vitamin D metabolism in the pathogenesis of age-related macular degenerationMargaux A Morrison, Alexandra C Silveira, Nancy Huynh, et al.
Cancer Discovery|November 8, 2011
An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathwayDeliang Guo, Felicia Reinitz, Mary Youssef, et al.
Cell Genomics|June 30, 2023
A systems biology approach uncovers novel disease mechanisms in age-related macular degenerationLuz D Orozco, Leah A Owen, Jeffrey Hofmann, et al.
Pageof 52